Not Signed In - ABILIFY(R) (Aripiprazole) Injection For Intramuscular Use For Adults With Agitation Associated With Schizophrenia Or Bipolar Mania Now Available
Wed, 13 Dec 2006 08:00 AM EST
... Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. today announced the launch of ABILIFY(R) (aripiprazole) Injection, an injectable form of ABILIFY, for intramuscular use. ABILIFY Injection provides rapid control of agitation in adults with schizophrenia or bipolar mania at primary endpoint (2 hours). The U.S. [click link for full article] ...
Related Topics
- Aripiprazole
- Schizophrenia
- Bipolar Disorder
- Clozapine
- Older Adults
- Menotropins
- Ziprasidone
- Oxcarbazepine
- Immune Globulin Intramuscular Injection
- Divalproex
- Dicyclomine Injection
- Cortisone Injection
- Paranoid Schizophrenia
- Schizophrenia - disorganized type
- Dimenhydrinate Injection
- Calcitonin Salmon Injection
- Sulfamethoxazole and Trimethoprim Injection
- Nephrotic Syndrome in Adults
- Brain tumor - adults
- Kidney Stones in Adults
email this page
print this page
bookmark this page
feedback on this page
